Company / SG&A per Share
Vera Therapeutics, Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.56
FY2025
5-year range
$0.56 / $1.56
FY2021-FY2025
Trend
+110.5%
vs FY2024
Sector context
#94 of 210
Health Care
What the data says
At $1.56, Vera Therapeutics, Inc.'s sg&a per share ranks #117 of 210 in the Health Care sector. Increased from $0.56 to $1.56 over the past 2 years.
Based on SEC 10-K filings.
1.56 in FY2025 with a 5-year CAGR of -34.2%.
Increased from $0.56 to $1.56 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +23.7%
- 5-Year CAGR
- -34.2%
- 10-Year CAGR
- -
Sector benchmark
#117 of 210 in Health CareTop 55% of 210This company $1.56 Sector average $40.75
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 110.5% year-over-year.
- Ranks #94 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | +110.5% |
| FY2024 | $0.74 | +33.0% |
| FY2023 | $0.56 | -32.5% |
| FY2022 | $0.82 | -7.0% |
| FY2021 | $0.89 | -93.0% |
| FY2020 | $12.62 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026